Wuhan-based Binhui Biotech has raised RMB600 million ($93 million) in Series C funding led by Shenzhen-based Share Capital. Other investors include CICC Capital, Vertex Ventures China and Qianhai FOF under Shenzhen Capital Group.
Existing backer Lapam Capital re-upped in the round. It is one of three major investors listed on Binhui's website alongside Lepu Medical and Fortune Capital. Founded in 2010, Binhui focuses on virotherapy,...
True North has agreed to sell India-based RDC Concrete, a company it has owned since 2005, to private equity-backed online construction marketplace Infra.market.
Freshworks, one of India's leading software-as-a-service (SaaS) businesses, traded strongly on its NASDAQ debut following a $1 billion IPO.
China-focused private equity firm FountainVest Partners has agreed to buy Ziwi, New Zealand’s leading exporter of pet food.